Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer.
- Resource Type
- Article
- Authors
- Makhlin, Igor; McAndrew, Nicholas P.; Wileyto, E. Paul; Clark, Amy S.; Holmes, Robin; Bottalico, Lisa N.; Mesaros, Clementina; Blair, Ian A.; Jeschke, Grace R.; Fox, Kevin R.; Domchek, Susan M.; Matro, Jennifer M.; Bradbury, Angela R.; Feldman, Michael D.; Hexner, Elizabeth O.; Bromberg, Jacqueline F.; DeMichele, Angela
- Source
- NPJ Breast Cancer; 11/11/2022, Vol. 8 Issue 1, p1-9, 9p
- Subject
- Language
- ISSN
- 23744677